Multi-drug Resistant Gram-negative Rods Found In Two Philippine Neonatal Intensive Care Units

According to researchers, hospital acquired infections have emerged as a significant health problem in developing areas. Neonatal mortality accounts for more than one third of all global child deaths each year. Sepsis is a leading cause of death within the first month of life and is often acquired through unhygienic care practices in healthcare facilities, which frequently have limited emphasis placed on standard infection control measures.

Over a 10-month period, BUSM researchers conducted studies for colonization and bloodstream infections with gentamicin or third generation cephalosporin-resistant GNR among all NICU infants weekly and then on the day of discharge. Researchers found a total of 1,997 resistant GNRs colonizing 1,831 neonates. Results also showed that 376 newborns became bacteremic with a total of 437 GNRs.

The most common GNR species identified were Klebsiella, Acinetobacter, Pseudomonas aeruginosa and Enterobacter. A high proportion of colonization and bacteremia at the two NICUs was with non-intestinal GNRs. Factors significantly associated with increased risk of bacteremia were mechanical ventilation and prematurity. Additionally, colonization with a resistant GNR was an independent risk factor for bacteremia.

"Colonization with a resistant GNR was an independent risk factor for sepsis," said senior author, Davidson Hamer, MD, associate professor of international health and medicine at Boston University School of Public Health, and director of Boston Medical Center's Travel Clinic. "The unusually high intensity of colonization pressure and disease with multidrug-resistant GNRs at these two NICUs constitutes an emerging health care crisis in the developing world."

The BUSM study appears online in the journal Infection Control and Hospital Epidemiology.

This study was funded by the United States Agency for International Development, the Health Resources and Services Administration and the National Institute of Allergy and Infectious Diseases. These organizations had no role in the design and conduct of the study, the collection, management, analysis and interpretation of the data, or the preparation, review and approval of the manuscript.